Many countries have cost sharing schemes in health insurance to control health care expenditures. The Dutch basic health insurance includes a mandatory deductible of currently 385 euros per adult per year. To avoid affordability problems, several municipalities offer a group contract for low-income people in which the mandatory deductible is ‘reinsured’. More specifically, this means that out-of-pocket spending under the deductible is covered by supplementary insurance. By comparing groups with and without the reinsurance option, this study examines whether low-income people are price-sensitive when it comes to pharmaceutical spending. We use a unique dataset from a Dutch health insurer with anonymized individual insurance claims for the period 2014–2017. The data allows for a clean difference-in-difference analysis as it contains both municipalities without reinsurance and municipalities that introduced reinsurance on January 1st 2017. We find that the introduction of reinsurance led to a statistically significant increase in pharmaceutical spending of 16% in the first quarter of 2017 and 7% in the second quarter. For the second half of 2017 the effect is small and not statistically significant. This study adds to the evidence that low-income people are indeed price-sensitive when it comes to pharmaceutical spending.

Additional Metadata
Keywords Deductible, Health insurance, Low-income people, Pharmaceutical spending, Reinsurance of consumer cost sharing
Persistent URL dx.doi.org/10.1016/j.healthpol.2019.07.004, hdl.handle.net/1765/118546
Journal Health Policy
Citation
Non, M. (Mariëlle), van Kleef, R.C, Van Der Galiën, O, & Douven, R.C.H.M. (2019). The effect of reinsuring a deductible on pharmaceutical spending: A Dutch case study on low-income people. Health Policy. doi:10.1016/j.healthpol.2019.07.004